Literature DB >> 33819261

COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19.

José Antonio Garcia-Gordillo1, Antonio Camiro-Zúñiga1, Mercedes Aguilar-Soto1, Dalia Cuenca1, Arturo Cadena-Fernández1, Latife Salame Khouri1, Jesica Naanous Rayek1, Moises Mercado2.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a systemic disease that can rapidly progress into acute respiratory failure and death. Timely identification of these patients is crucial for a proper administration of health-care resources.
OBJECTIVE: To develop a predictive score that estimates the risk of invasive mechanical ventilation (IMV) among patients with COVID-19. STUDY
DESIGN: Retrospective cohort study of 401 COVID-19 patients diagnosed from March 12, to August 10, 2020. The score development cohort comprised 211 patients (52.62% of total sample) whereas the validation cohort included 190 patients (47.38% of total sample). We divided participants according to the need of invasive mechanical ventilation (IMV) and looked for potential predictive variables.
RESULTS: We developed two predictive scores, one based on Interleukin-6 (IL-6) and the other one on the Neutrophil/Lymphocyte ratio (NLR), using the following variables: respiratory rate, SpO2/FiO2 ratio and lactic dehydrogenase (LDH). The area under the curve (AUC) in the development cohort was 0.877 (0.823-0.931) using the NLR based score and 0.891 (0.843-0.939) using the IL-6 based score. When compared with other similar scores developed for the prediction of adverse outcomes in COVID-19, the COVID-IRS scores proved to be superior in the prediction of IMV.
CONCLUSION: The COVID-IRS scores accurately predict the need for mechanical ventilation in COVID-19 patients using readily available variables taken upon admission. More studies testing the applicability of COVID-IRS in other centers and populations, as well as its performance as a triage tool for COVID-19 patients are needed.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33819261     DOI: 10.1371/journal.pone.0248357

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  7 in total

1.  Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City.

Authors:  Jason Zucker; Angela Gomez-Simmonds; Lawrence J Purpura; Sherif Shoucri; Elijah LaSota; Nicholas E Morley; Brit W Sovic; Marvin A Castellon; Deborah A Theodore; Logan L Bartram; Benjamin A Miko; Matthew L Scherer; Kathrine A Meyers; William C Turner; Maureen Kelly; Martina Pavlicova; Cale N Basaraba; Matthew R Baldwin; Daniel Brodie; Kristin M Burkart; Joan Bathon; Anne-Catrin Uhlemann; Michael T Yin; Delivette Castor; Magdalena E Sobieszczyk
Journal:  J Clin Med       Date:  2021-08-11       Impact factor: 4.964

2.  Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Percentage Ratio as Predictors of In-hospital Mortality in Sepsis. An Observational Cohort Study.

Authors:  Vasileios Karamouzos; Themistoklis Paraskevas; Francesk Mulita; Sofia Karteri; Eleousa Oikonomou; Nikolaos Ntoulias; Nikolaos Dimitrios Pantzaris; Vayanna Bourganou; Dimitrios Velissaris
Journal:  Mater Sociomed       Date:  2022-03

3.  Threshold of increase in oxygen demand to predict mechanical ventilation use in novel coronavirus disease 2019: A retrospective cohort study incorporating restricted cubic spline regression.

Authors:  Ryo Yamamoto; Ryo Takemura; Asako Yamamoto; Kazuki Matsumura; Daiki Kaito; Koichiro Homma; Michihiko Wada; Junichi Sasaki
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

4.  Risk factors for severe COVID-19 differ by age for hospitalized adults.

Authors:  Sevda Molani; Patricia V Hernandez; Ryan T Roper; Venkata R Duvvuri; Andrew M Baumgartner; Jason D Goldman; Nilüfer Ertekin-Taner; Cory C Funk; Nathan D Price; Noa Rappaport; Jennifer J Hadlock
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

Review 5.  Liver damage in the context of SARS-CoV-2. Covid-19 treatment and its effects on the liver.

Authors:  Adina Maria Kamal; Constantin Kamal Kamal; Denisa Marilena Săbiescu; Dragos Ovidiu Alexandru; Paul Mitruț
Journal:  J Med Life       Date:  2022-06

Review 6.  Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection.

Authors:  Cristian Arriaga-Canon; Laura Contreras-Espinosa; Rosa Rebollar-Vega; Rogelio Montiel-Manríquez; Alberto Cedro-Tanda; José Antonio García-Gordillo; Rosa María Álvarez-Gómez; Francisco Jiménez-Trejo; Clementina Castro-Hernández; Luis A Herrera
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

7.  Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care-An experience from South India.

Authors:  Narendran Gopalan; Sumathi Senthil; Narmadha Lakshmi Prabakar; Thirumaran Senguttuvan; Adhin Bhaskar; Muthukumaran Jagannathan; Ravi Sivaraman; Jayalakshmi Ramasamy; Ponnuraja Chinnaiyan; Vijayalakshmi Arumugam; Banumathy Getrude; Gautham Sakthivel; Vignes Anand Srinivasalu; Dhanalakshmi Rajendran; Arunjith Nadukkandiyil; Vaishnavi Ravi; Sadiqa Nasreen Hifzour Rahamane; Nirmal Athur Paramasivam; Tamizhselvan Manoharan; Maheshwari Theyagarajan; Vineet Kumar Chadha; Mohan Natrajan; Baskaran Dhanaraj; Manoj Vasant Murhekar; Shanthi Malar Ramalingam; Padmapriyadarsini Chandrasekaran
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.